AHI 500 Pill - purple capsule/oblong
Pill with imprint AHI 500 is Purple, Capsule/Oblong and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Accord Healthcare.
Mycophenolate mofetil is used in the treatment of Nephrotic Syndrome; Organ Transplant, Rejection Prophylaxis; Graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AHI 500
Mycophenolate Mofetil
- Imprint
- AHI 500
- Strength
- 500 mg
- Color
- Purple
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Accord Healthcare
- National Drug Code (NDC)
- 16729-0019
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
povidone k90,
microcrystalline cellulose,
hydroxypropyl cellulose,
magnesium silicate,
FD&C Blue No. 2,
ferrosoferric oxide,
ferric oxide red,
polyethylene glycol 400,
titanium dioxide,
hypromellose 2910 (6 mPa.s)
Note: Inactive ingredients may vary.
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.